<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210703051765N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-16</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of exercise therapy and lifestyle modification on metabolic syndrome components in patients with severe mental illness</public_title>
      <acronym></acronym>
      <scientific_title>The effect of exercise therapy and lifestyle modification on metabolic syndrome components in patients with severe mental illness referred to exercise therapy unit in outpatient setting</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57281</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: schizophrenia. Condition 2: schizoaffective disorder. Condition 3: bipolar disorder. Condition 4: depressive disorders without psychotic feature. Condition 5: depressive disorders with psychotic feature.</hc_freetext>
      <i_freetext>The intervention includes exercise therapy and a nutrition education program. The nutrition educational program includes 4 group educational sessions. The intervention to increase physical activity includes 20 sessions of exercise therapy. Nutrition education program: In the first 4 sessions, patients will participate in a group educational session and then receive exercise therapy intervention. In the following sessions, the individual's nutritional habits will be explored and then exercise therapy will be provided. The training sessions will be held by a trained nurse, occupational therapist or psychologist who has participated in a workshop. These sessions are held every week in a group manner (5-8 people). The duration of each session will be about 30-45 minutes. The first session includes being familiar with the team members and reviewing the basics principles of healthy eating. In the second and third sessions, different food categories, the fiber content of foods, different food calories and the importance of physical activity will be explained. In the fourth session, in addition to review the previous contents, the patients' misconceptions about nutrition, will be discussed. The exercise therapy as an intervention to increase physical activity: The exercise program including 5 to 10 minutes of warm-up (low-intensity exercise with flexibility movements), 15 to 30 minutes of aerobic exercise includes stationary and elliptical cycling, 15 minutes of strength training with the device for upper and lower limbs and 5 minutes of cooling. Exercise intervention will be the same for all patients, and aerobic exercise and moderate-intensity strength exercise will be defined according to the Borg table (between 11 and 14). Exercise therapy sessions will be performed twice a week for 10 weeks (20 sessions of exercise therapy) under the supervision of a trained trainer. The patient's vital signs will be recorded by the nurse, before and after the intervention. The exercise program will be performed under the supervision of a coach for 30-45 minutes..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is According to ethical concerns the data will not be published.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Mirsepassi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Roozbeh Hospital, South Kargar Ave, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1333715914</zip>
        <telephone>+98 21 5541 2222</telephone>
        <email>mirsepassizahra@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Mirsepassi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Roozbeh Hospital, South Kargar Ave, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1333715914</zip>
        <telephone>+98 21 5541 2222</telephone>
        <email>mirsepassizahra@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with severe mental illness
In the remission phase
Under the treatments</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Substance use in the last month
Presence of any uncontrolled medical or neurological disease
Diabetes mellitus
Heart disease
Uncontrolled seizure
Musculoskeletal disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F20</hc_code>
      <hc_code>F25</hc_code>
      <hc_code>F31</hc_code>
      <hc_code>F32.2</hc_code>
      <hc_code>F32.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Schizophrenia</hc_keyword>
      <hc_keyword>Schizoaffective disorders</hc_keyword>
      <hc_keyword>Bipolar disorder</hc_keyword>
      <hc_keyword>Major depressive disorder without psychotic features</hc_keyword>
      <hc_keyword>Major depressive disorder with psychotic features</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention includes exercise therapy and a nutrition education program. The nutrition educational program includes 4 group educational sessions. The intervention to increase physical activity includes 20 sessions of exercise therapy. Nutrition education program: In the first 4 sessions, patients will participate in a group educational session and then receive exercise therapy intervention. In the following sessions, the individual's nutritional habits will be explored and then exercise therapy will be provided. The training sessions will be held by a trained nurse, occupational therapist or psychologist who has participated in a workshop. These sessions are held every week in a group manner (5-8 people). The duration of each session will be about 30-45 minutes. The first session includes being familiar with the team members and reviewing the basics principles of healthy eating. In the second and third sessions, different food categories, the fiber content of foods, different food calories and the importance of physical activity will be explained. In the fourth session, in addition to review the previous contents, the patients' misconceptions about nutrition, will be discussed. The exercise therapy as an intervention to increase physical activity: The exercise program including 5 to 10 minutes of warm-up (low-intensity exercise with flexibility movements), 15 to 30 minutes of aerobic exercise includes stationary and elliptical cycling, 15 minutes of strength training with the device for upper and lower limbs and 5 minutes of cooling. Exercise intervention will be the same for all patients, and aerobic exercise and moderate-intensity strength exercise will be defined according to the Borg table (between 11 and 14). Exercise therapy sessions will be performed twice a week for 10 weeks (20 sessions of exercise therapy) under the supervision of a trained trainer. The patient's vital signs will be recorded by the nurse, before and after the intervention. The exercise program will be performed under the supervision of a coach for 30-45 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Waist circumstance. Timepoint: Before starting the intervention/after 10 sessions of exercise therapy/after 20 sessions of exercise therapy. Method of measurement: Centimeter tape measure.</prim_outcome>
      <prim_outcome>Weight. Timepoint: Before starting the intervention/after 10 sessions of exercise therapy/after 20 sessions of exercise therapy. Method of measurement: Scale.</prim_outcome>
      <prim_outcome>Blood Glucose. Timepoint: Before starting the intervention and after 20 sessions of exercise therapy. Method of measurement: Lab tests.</prim_outcome>
      <prim_outcome>Lipid profile. Timepoint: Before starting the intervention and after 20 sessions of exercise therapy. Method of measurement: Lab tests.</prim_outcome>
      <prim_outcome>Systolic blood pressure. Timepoint: Before starting the intervention/after 10 sessions of exercise therapy/after 20 sessions of exercise therapy. Method of measurement: Sphygmomanometer.</prim_outcome>
      <prim_outcome>Diastolic Blood pressure. Timepoint: Before starting the intervention/after 10 sessions of exercise therapy/after 20 sessions of exercise therapy. Method of measurement: Sphygmomanometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Global assessment of functioning. Timepoint: Before the intervention/at the end of the intervention. Method of measurement: GAF scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-22</approval_date>
        <contact_name>Ethics committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Tehran University of Medical Sciences, Poorsina Ave, Ghods Ave, Enghelab Ave Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
